Effects of Social Media Use on Young Adults' E-Cigarette Use
NCT ID: NCT06142877
Last Updated: 2024-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2023-12-04
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does reducing social media use change young adults' e-cigarette use?
* Does reducing social media use change things such as young adults' mental health and what they see on social media?
Participants will complete surveys and submit screenshots showing how much time they spend on social media.
Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults
NCT06129123
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
NCT07116837
Tobacco Status Project: Social Media Intervention for Young Adult Smokers
NCT02207036
Impact of E-Cigarette Prevention Messages on Adolescents
NCT05985538
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
NCT05994209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Social Media Use Reduction
Social Media Use Reduction
Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.
Social Media Use as Usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Social Media Use Reduction
Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Daily social media use
* Ownership of a smartphone
* Vaping (i.e., use of a nicotine e-cigarette) on 1-19 days of the past 30 days
* Residing in the United States
Exclusion Criteria
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
University of Southern California
OTHER
University of Wisconsin, Madison
OTHER
National Institute on Drug Abuse (NIDA)
NIH
University of Oklahoma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin A Vogel, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Oklahoma
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15427
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.